Published in Circulation on January 25, 2010
Heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation (2011) 31.98
Heart disease and stroke statistics--2013 update: a report from the American Heart Association. Circulation (2012) 30.79
Heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation (2013) 28.02
Sudden cardiac death prediction and prevention: report from a National Heart, Lung, and Blood Institute and Heart Rhythm Society Workshop. Circulation (2010) 2.94
Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association. Circulation (2017) 2.76
Prognosis research strategy (PROGRESS) 1: a framework for researching clinical outcomes. BMJ (2013) 2.31
Fever-induced Brugada pattern: how common is it and what does it mean? Heart Rhythm (2013) 2.25
Genetic variants in SCN5A promoter are associated with arrhythmia phenotype severity in patients with heterozygous loss-of-function mutation. Heart Rhythm (2012) 1.51
Programmed Ventricular Stimulation for Risk Stratification in the Brugada Syndrome: A Pooled Analysis. Circulation (2016) 1.49
Inherited calcium channelopathies in the pathophysiology of arrhythmias. Nat Rev Cardiol (2012) 1.44
Brugada syndrome and its relevance in the perioperative period. Ann Card Anaesth (2015) 1.43
Genetic, molecular and cellular mechanisms underlying the J wave syndromes. Circ J (2012) 1.40
The spectrum of epidemiology underlying sudden cardiac death. Circ Res (2015) 1.26
Genetic testing for inherited cardiac disease. Nat Rev Cardiol (2013) 1.20
J-wave syndromes: Brugada and early repolarization syndromes. Heart Rhythm (2015) 1.14
Risk stratification in individuals with the Brugada type 1 ECG pattern without previous cardiac arrest: usefulness of a combined clinical and electrophysiologic approach. Eur Heart J (2010) 1.10
Potassium-channel mutations and cardiac arrhythmias--diagnosis and therapy. Nat Rev Cardiol (2012) 1.04
Current perspectives in genetic cardiovascular disorders: from basic to clinical aspects. Heart Vessels (2013) 1.02
The genetic component of Brugada syndrome. Front Physiol (2013) 0.94
Genetics of Brugada syndrome. J Hum Genet (2015) 0.94
Electrocardiographic methods for diagnosis and risk stratification in the Brugada syndrome. J Saudi Heart Assoc (2014) 0.91
Electrophysiological Mechanisms of Brugada Syndrome: Insights from Pre-clinical and Clinical Studies. Front Physiol (2016) 0.88
J-Wave syndromes expert consensus conference report: Emerging concepts and gaps in knowledge. Heart Rhythm (2016) 0.87
Brugada Syndrome: Clinical, Genetic, Molecular, Cellular, and Ionic Aspects. Curr Probl Cardiol (2015) 0.86
Brugada syndrome: clinical and genetic findings. Genet Med (2015) 0.86
Sleep-disordered breathing in patients with the Brugada syndrome. Am J Cardiol (2011) 0.85
Reduced Penetrance and Variable Expression of SCN5A Mutations and the Importance of Co-inherited Genetic Variants: Case Report and Review of the Literature. Indian Pacing Electrophysiol J (2014) 0.85
Diagnostic dilemmas: overlapping features of brugada syndrome and arrhythmogenic right ventricular cardiomyopathy. Front Physiol (2012) 0.84
Phenotypical manifestations of mutations in the genes encoding subunits of the cardiac voltage-dependent L-type calcium channel. Circ Res (2011) 0.84
Ventricular repolarization markers for predicting malignant arrhythmias in clinical practice. World J Clin Cases (2015) 0.82
Sudden cause of cardiac death-be aware of me: a case report and short review on brugada syndrome. Case Rep Med (2010) 0.82
Brugada ECG pattern: a physiopathological prospective study based on clinical, electrophysiological, angiographic, and genetic findings. Front Physiol (2012) 0.82
Arrhythmic substrate, slowed propagation and increased dispersion in conduction direction in the right ventricular outflow tract of murine Scn5a+/- hearts. Acta Physiol (Oxf) (2014) 0.81
Pathogenesis and management of Brugada syndrome. Nat Rev Cardiol (2016) 0.78
The Brugada Syndrome: A Rare Arrhythmia Disorder with Complex Inheritance. Front Cardiovasc Med (2016) 0.78
[The ICD as primary prevention. Rare indications]. Herzschrittmacherther Elektrophysiol (2010) 0.78
Prognosis after implantation of cardioverter-defibrillators in Korean patients with Brugada syndrome. Yonsei Med J (2014) 0.77
Genetic testing for channelopathies, more than ten years progress and remaining challenges. J Cardiovasc Dis Res (2010) 0.77
Genetics of inherited primary arrhythmia disorders. Appl Clin Genet (2015) 0.77
Disease-targeted sequencing of ion channel genes identifies de novo mutations in patients with non-familial Brugada syndrome. Sci Rep (2014) 0.76
Novel Therapeutic Strategies for the Management of Ventricular Arrhythmias Associated with the Brugada Syndrome. Expert Opin Orphan Drugs (2015) 0.76
[Primary and secondary prophylactic ICD therapy in congenital electrical and structural cardiomyopathies]. Herzschrittmacherther Elektrophysiol (2015) 0.76
Fever-Induced Brugada Syndrome. J Investig Med High Impact Case Rep (2015) 0.75
Brugada Syndrome:Risk Stratification And Management. J Atr Fibrillation (2016) 0.75
Fever-induced electrocardiographic changes. J Gen Intern Med (2014) 0.75
Intermittent brugada syndrome presenting with syncope in an adult female. Case Rep Emerg Med (2014) 0.75
Brugada syndrome: Controversies in Risk stratification and Management. Indian Pacing Electrophysiol J (2010) 0.75
Genetics of Brugada syndrome. J Arrhythm (2016) 0.75
Inappropriate implantable cardioverter-defibrillator shocks in Brugada syndrome: Pattern in primary and secondary prevention. Indian Pacing Electrophysiol J (2016) 0.75
Flecainide challenge test: Predictors of unmasking of type 1 Brugada ECG pattern among those with non-type 1 Brugada ECG pattern. Indian Pacing Electrophysiol J (2016) 0.75
Brugada Syndrome: Defining the Risk in Asymptomatic Patients. Arrhythm Electrophysiol Rev (2016) 0.75
Does difference in ICD indication result in a difference in inappropriate shock risk? Indian Pacing Electrophysiol J (2016) 0.75
Programmed electrical stimulation for patients with asymptomatic Brugada syndrome? The shock-filled debate continues. J Am Coll Cardiol (2015) 0.75
A tick-borne illness unmasking asymptomatic Brugada syndrome. Oxf Med Case Reports (2015) 0.75
Monogenec Arrhythmic Syndromes: From Molecular and Genetic Aspects to Bedside. Acta Naturae (2016) 0.75
Risk factors for cardiac events in patients with Brugada syndrome: A PRISMA-compliant meta-analysis and systematic review. Medicine (Baltimore) (2016) 0.75
Risk Stratification and Therapeutic Approach in Brugada Syndrome. Arrhythm Electrophysiol Rev (2012) 0.75
Recent advances in genetic testing and counseling for inherited arrhythmias. J Arrhythm (2016) 0.75
Type 1 Brugada Pattern Unmasked During the Recovery Period of an Exercise Stress Test. Arq Bras Cardiol (2016) 0.75
The dilemma of an incidental preoperative electrocardiogram showing a Brugada phenotype. BMJ Case Rep (2011) 0.75
Device therapy: a subcutaneous ICD--preliminary results. Nat Rev Cardiol (2010) 0.75
C-reactive protein levels in the brugada syndrome. Cardiol Res Pract (2011) 0.75
The Diagnosis, Risk Stratification, and Treatment of Brugada Syndrome. Dtsch Arztebl Int (2015) 0.75
Complex genetic background in a large family with Brugada syndrome. Physiol Rep (2015) 0.75
Brugada syndrome with elevated cardiac biomarkers. BMJ Case Rep (2013) 0.75
Beneficial Effects of Isoproterenol and Quinidine in the Treatment of Ventricular Fibrillation in Brugada Syndrome. Case Rep Cardiol (2015) 0.75
J-Wave syndromes expert consensus conference report: Emerging concepts and gaps in knowledge. J Arrhythm (2016) 0.75
Almanac 2011: Cardiac Arrhythmias and Pacing. The National Society Journals Present Selected Research that has Driven Recent Advances in Clinical Cardiology. Mater Sociomed (2011) 0.75
ST elevation without cardio-pulmonary symptoms. J Arrhythm (2016) 0.75
Meta-analysis of Fragmented QRS as an Electrocardiographic Predictor for Arrhythmic Events in Patients with Brugada Syndrome. Front Physiol (2017) 0.75
[Brugada syndrome]. Herzschrittmacherther Elektrophysiol (2012) 0.75
Brugada Syndrome:Risk Stratification And Management. J Atr Fibrillation (2016) 0.75
[Indications for implantable loop recorders in patients with channelopathies and ventricular tachycardias]. Herzschrittmacherther Elektrophysiol (2016) 0.75
Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell (1998) 17.76
Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell (1997) 15.96
OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature (1999) 12.32
osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev (1998) 7.81
Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias. Circulation (2001) 7.47
Genetic basis and molecular mechanism for idiopathic ventricular fibrillation. Nature (1998) 7.26
Chiari I malformation redefined: clinical and radiographic findings for 364 symptomatic patients. Neurosurgery (1999) 6.89
Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand. Proc Natl Acad Sci U S A (1999) 5.78
RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism. Proc Natl Acad Sci U S A (2000) 3.95
Proposed diagnostic criteria for the Brugada syndrome. Eur Heart J (2002) 3.01
Cardiac conduction defects associate with mutations in SCN5A. Nat Genet (1999) 2.73
Novel SCN5A mutation leading either to isolated cardiac conduction defect or Brugada syndrome in a large French family. Circulation (2001) 2.65
Electrophysiologic characteristics of cells spanning the left ventricular wall of human heart: evidence for presence of M cells. J Am Coll Cardiol (1995) 2.42
Post-infarction depression and incomplete recovery 6 months after acute myocardial infarction. Lancet (1994) 2.39
Multisite pacing as a supplemental treatment of congestive heart failure: preliminary results of the Medtronic Inc. InSync Study. Pacing Clin Electrophysiol (1998) 2.38
Elimination of atrioventricular nodal reentrant tachycardia using discrete slow potentials to guide application of radiofrequency energy. Circulation (1992) 2.36
Functional beta3-adrenoceptor in the human heart. J Clin Invest (1996) 2.32
Permanent left ventricular pacing with transvenous leads inserted into the coronary veins. Pacing Clin Electrophysiol (1998) 2.27
Identification of a possible pathogenic link between congenital long QT syndrome and epilepsy. Neurology (2008) 2.21
Hemodynamic importance of preserving the normal sequence of ventricular activation in permanent cardiac pacing. Am Heart J (1995) 2.15
Osteoprotegerin ligand modulates murine osteoclast survival in vitro and in vivo. Am J Pathol (2000) 2.12
Unique and shared functions of different connexins in mice. Curr Biol (2000) 2.10
Per-operative hemodynamic instability in normotensive patients with incidentally discovered pheochromocytomas. J Clin Endocrinol Metab (2014) 1.97
Comparative effects of permanent biventricular and right-univentricular pacing in heart failure patients with chronic atrial fibrillation. Eur Heart J (2002) 1.97
Acute hemodynamic effects of biventricular DDD pacing in patients with end-stage heart failure. J Am Coll Cardiol (1998) 1.92
KCNE1 mutations cause jervell and Lange-Nielsen syndrome. Nat Genet (1997) 1.90
Is T-wave alternans testing feasible in candidates for prophylactic implantable defibrillators? Neth Heart J (2011) 1.89
De novo mutation in the SCN5A gene associated with early onset of sudden infant death. Circulation (2001) 1.88
Bibliometric data in clinical cardiology revisited. The case of 37 Dutch professors. Neth Heart J (2011) 1.79
Catecholaminergic polymorphic ventricular tachycardia: RYR2 mutations, bradycardia, and follow up of the patients. J Med Genet (2005) 1.78
A pilot experience with permanent biventricular pacing to treat advanced heart failure. Am Heart J (2000) 1.78
Incidence and clinical significance of left ventricular thrombus in tako-tsubo cardiomyopathy assessed with echocardiography. QJM (2008) 1.71
Targeting the slow pathway for atrioventricular nodal reentrant tachycardia: initial results and long-term follow-up in 379 consecutive patients. Eur Heart J (2001) 1.71
Novel Brugada syndrome-causing mutation in ion-conducting pore of cardiac Na+ channel does not affect ion selectivity properties. Acta Physiol Scand (2005) 1.67
Molecular diagnosis in a child with sudden infant death syndrome. Lancet (2001) 1.66
Prognostic value of heart rate variability for sudden death and major arrhythmic events in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol (1999) 1.66
The negative inotropic effect of beta3-adrenoceptor stimulation is mediated by activation of a nitric oxide synthase pathway in human ventricle. J Clin Invest (1998) 1.66
Comparison of long-term outcome of alcoholic and idiopathic dilated cardiomyopathy. Eur Heart J (2000) 1.66
Long-term effects of biatrial synchronous pacing to prevent drug-refractory atrial tachyarrhythmia: a nine-year experience. J Cardiovasc Electrophysiol (2000) 1.65
Predictors of in-hospital mortality after DC catheter ablation of atrioventricular junction. Results of a prospective, international, multicenter study. Circulation (1991) 1.64
Hospital readmission after transvenous cardioverter/defibrillator implantation; a single centre study. Eur Heart J (2000) 1.62
Efficacy of antiarrhythmic drugs in patients with arrhythmogenic right ventricular disease. Results in patients with inducible and noninducible ventricular tachycardia. Circulation (1992) 1.61
An anatomically and electrogram-guided stepwise approach for effective and safe catheter ablation of the fast pathway for elimination of atrioventricular node reentrant tachycardia. J Am Coll Cardiol (1995) 1.61
Gene-specific differences in the circadian variation of ventricular repolarization in the long QT syndrome: a key to sudden death during sleep? Ital Heart J (2000) 1.59
Multitissular involvement in a family with LMNA and EMD mutations: Role of digenic mechanism? Neurology (2007) 1.59
[Initial diagnostic strategy in the case of transient losses of consciousness: the importance of the medical history]. Ned Tijdschr Geneeskd (2003) 1.55
Erroneous discharge of an implantable cardioverter defibrillator caused by an electric razor. Pacing Clin Electrophysiol (1995) 1.54
Electrophysiological effects of catheter ablation of inferior vena cava-tricuspid annulus isthmus in common atrial flutter. Circulation (1996) 1.54
Optimal right ventricular pacing site in chronically implanted patients: a prospective randomized crossover comparison of apical and outflow tract pacing. J Am Coll Cardiol (1999) 1.53
Prevalence of coronary artery disease in a general population without suspicion of coronary artery disease: angiographic analysis of subjects aged 40 to 70 years referred for catheter ablation therapy. Eur Heart J (2000) 1.52
Genetic knowledge and counselling skills of Dutch cardiologists: sufficient for the genomics era? Eur Heart J (2003) 1.52
Intraoperative radiofrequency ablation of chronic atrial fibrillation: a left atrial curative approach by elimination of anatomic "anchor" reentrant circuits. J Cardiovasc Electrophysiol (1999) 1.52
Is there a need for routine testing of ICD defibrillation capacity? Results from more than 1000 studies. Eur Heart J (2000) 1.51
Extracardiac contributions to chest pain perception in patients 6 months after acute myocardial infarction. Am Heart J (1999) 1.50
Prevalence of left atrial chamber and appendage thrombi in patients with atrial flutter and its clinical significance. J Am Coll Cardiol (2001) 1.49
Haemodynamic quantification of different provocation manoeuvres by simultaneous measurement of right and left atrial pressure: implications for the echocardiographic detection of persistent foramen ovale. Eur J Echocardiogr (2001) 1.47
Successful radiofrequency catheter ablation of right sided accessory pathways during sustained atrial fibrillation. Eur Heart J (1995) 1.47
Laparoscopy as the investigation and treatment of choice for urinary incontinence caused by small 'invisible' dysplastic kidneys with infrasphincteric ureteric ectopia. BJU Int (1999) 1.47
A multicentre, double-blind randomized crossover comparative study on the efficacy and safety of dofetilide vs sotalol in patients with inducible sustained ventricular tachycardia and ischaemic heart disease. Eur Heart J (2001) 1.46
[Genetic identification of patients and families with a long-QT syndrome: large regional differences in the result of 10 years]. Ned Tijdschr Geneeskd (2007) 1.46
Autistic symptoms among children and young adults with isodicentric chromosome 15. Am J Med Genet (2000) 1.44
Prevalence, characteristics, and prognosis role of type 1 ST elevation in the peripheral ECG leads in patients with Brugada syndrome. Heart Rhythm (2013) 1.44
Doppler echocardiographic assessment of the pressure gradient during bicycle ergometry in hypertrophic cardiomyopathy. Am J Cardiol (1992) 1.43
[18-year old patient with anti-epileptic therapy and sudden cardiac death]. Z Kardiol (2003) 1.41
[Acute reversible pan-dysautonomia: effect of erythromycin on gastrointestinal involvement]. Gastroenterol Clin Biol (1997) 1.40
The works of Dirk Durrer (1918-1984). Neth Heart J (2012) 1.39
Affective disorders and survival after acute myocardial infarction. Results from the post-infarction late potential study. Eur Heart J (1991) 1.39
[Medication for ADHD and the risk of cardiovascular mortality]. Ned Tijdschr Geneeskd (2006) 1.39
Temperature-controlled radiofrequency catheter ablation of manifest accessory pathways. Eur Heart J (1996) 1.39
Sodium channel blocker tests allow a clear distinction of electrophysiological characteristics and prognosis in patients with a type 2 or 3 Brugada electrocardiogram pattern. Heart Rhythm (2008) 1.39
Patients with valvular heart disease presenting with sustained ventricular tachyarrhythmias or syncope: results of programmed ventricular stimulation and long-term follow-up. Circulation (1997) 1.39
Electrocardiographic predictive factors of long-term clinical improvement with multisite biventricular pacing in advanced heart failure. Am J Cardiol (1999) 1.39
Implantable cardioverter/defibrillators (ICD): a new lead-system using transvenous-subcutaneous approach in patients with prior cardiac surgery. Eur J Cardiothorac Surg (1991) 1.38
Effects of enflurane on inducibility of ventricular tachycardia. Am J Cardiol (1991) 1.38
Dynamic analysis of the QT interval in long QT1 syndrome patients with a normal phenotype. Eur Heart J (2001) 1.37
ESCWGA/NASPE/P experts consensus statement: living anatomy of the atrioventricular junctions. A guide to electrophysiologic mapping. Working Group of Arrhythmias of the European Society of Cardiology. North American Society of Pacing and Electrophysiology. J Cardiovasc Electrophysiol (1999) 1.37
Pyloromyotomy: comparison between laparoscopic and open surgical techniques. J Laparoendosc Surg (1995) 1.37
Left atrial chamber and appendage function after internal atrial defibrillation: a prospective and serial transesophageal echocardiographic study. J Am Coll Cardiol (1997) 1.32
Heart rate variability in mice: a theoretical and practical guide. Exp Physiol (2007) 1.31
The Hirsch-index: a simple, new tool for the assessment of scientific output of individual scientists: The case of Dutch professors in clinical cardiology. Neth Heart J (2009) 1.30
Radiofrequency catheter ablation of atrial tachycardias. Am Heart J (1996) 1.30
Physiological relationship between AV interval and heart rate in healthy subjects: applications to dual chamber pacing. Pacing Clin Electrophysiol (1986) 1.28
Pacemaker lead infection: echocardiographic features, management, and outcome. Heart (1999) 1.28
C-terminal HERG mutations: the role of hypokalemia and a KCNQ1-associated mutation in cardiac event occurrence. Circulation (1999) 1.26
Which are the most reliable predictors of recurrence of atrial fibrillation after transcatheter ablation?: a meta-analysis. Int J Cardiol (2012) 1.22
Effects of permanent dual-chamber pacing on mitral regurgitation in hypertrophic obstructive cardiomyopathy. Eur Heart J (1999) 1.22
Hevein, a lectin-like protein from Hevea brasiliensis (rubber tree) is involved in the coagulation of latex. J Biol Chem (1994) 1.21
Long-term follow-up of right ventricular monomorphic extrasystoles. J Am Coll Cardiol (2001) 1.20
Usefulness of biventricular pacing in patients with congestive heart failure and right bundle branch block. Am J Cardiol (2001) 1.19
Serum alpha-L-fucosidase: a new marker for the diagnosis of primary hepatic carcinoma? Hepatology (1984) 1.19